CSIMarket
 


Novocure Limited  (NVCR)
Other Ticker:  
 
 

NVCR's Net Income Growth by Quarter and Year

Novocure Limited's Net Income results by quarter and year




NVCR Net Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -47.08 -37.30 -26.46 4.92
III Quarter September -49.49 -26.58 -13.12 9.28
II Quarter June -57.42 -24.01 -14.64 1.66
I Quarter March -53.06 -4.65 -4.13 3.95
FY   -207.05 -92.54 -58.35 19.81



NVCR Net Income fourth quarter 2023 Y/Y Growth Comment
Novocure Limited in the fourth quarter 2023 recorded net loss of $ -47.08 millions.

According to the results reported in the fourth quarter 2023, Novocure Limited achieved the best Net Income growth in Medical Equipment & Supplies industry. While Novocure Limited' s Net Income no change of % ranks overall at the positon no. in the fourth quarter 2023.




NVCR Net Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - 15.49 %
III Quarter September - - - 380.83 %
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Novocure Limited's fourth quarter 2023 Net Income $ -47.08 millions NVCR's Income Statement
Novocure Limited's fourth quarter 2022 Net Income $ -37.30 millions Quarterly NVCR's Income Statement
New: More NVCR's historic Net Income Growth >>


NVCR Net Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -46.98 %
III Quarter September - - - 459.04 %
II Quarter June - - - -57.97 %
I Quarter March - - - -7.28 %
FY (Year on Year)   - - - -




Net Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Novocure Limited's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NVCR's IV. Quarter Q/Q Net Income Comment
Although Novocure Limited in the IV. Quarter 2023 revealed net loss of $ -47.08 millions, management point out, that current results are recovery relative to the -49.49 millions in the third quarter.

Within Medical Equipment & Supplies industry Novocure Limited achieved highest sequential Net Income growth. While Novocure Limited's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NVCR's IV. Quarter Q/Q Net Income Comment
Although Novocure Limited in the IV. Quarter 2023 showed net loss of $ -47.08 millions, management said, that this are improvement in contrast to the -49.49 millions in the third quarter.

Within Medical Equipment & Supplies industry Novocure Limited achieved highest sequential Net Income growth. While Novocure Limited's Net Income growth quarter on quarter, overall rank is .


Novocure Limited's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Net Income 12 Months Ending $ -207.04 $ -197.27 $ -174.36 $ -140.95 $ -92.53
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Novocure Limited' has realized cumulative trailing twelve months net loss of $ -207 millions in the Dec 31 2023 period.
The results are getting worse as the cumulative net loss is inflating from $ -197.27 millions for the period from Sep 30 2023 to Dec 31 2022 and $ -81.689 millions from the TTM period ending Dec 31 2022 Finley  Walker mentioned.

Novocure Limited achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Novocure Limited' has realized cumulative trailing twelve months net loss of $ -207 millions in the Dec 31 2023 period.
The business is getting worse as the cumulative net loss is inflating from $ -197.27 millions in TTM ending quarter Sep 30 2023 and $ -81.689 millions for the twelve months ending in the quarter Dec 31 2022.

Novocure Limited achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Medical Equipment & Supplies Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
NVCR's Net Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for NVCR's Competitors
Net Income Growth for Novocure Limited's Suppliers
Net Income Growth for NVCR's Customers

You may also want to know
NVCR's Annual Growth Rates NVCR's Profitability Ratios NVCR's Asset Turnover Ratio NVCR's Dividend Growth
NVCR's Roe NVCR's Valuation Ratios NVCR's Financial Strength Ratios NVCR's Dividend Payout Ratio
NVCR's Roa NVCR's Inventory Turnover Ratio NVCR's Growth Rates NVCR's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Income for the quarter ending Dec 31 2023
Integer Holdings Corporation45.48%$ 45.482 millions
Cadre Holdings Inc 45.39%$ 45.386 millions
Chemed Corporation44.95%$ 44.952 millions
Viemed Healthcare Inc 42.62%$ 42.617 millions
Healthcare Services Group Inc 39.85%$ 39.848 millions
Ufp Technologies Inc 37.18%$ 37.178 millions
Catalyst Pharmaceuticals Inc 36.80%$ 36.799 millions
National Research Corporation33.38%$ 33.384 millions
West Pharmaceutical Services Inc 33.01%$ 33.010 millions
Baxter International Inc 32.97%$ 32.973 millions
Hologic Inc31.54%$ 31.537 millions
Semler Scientific Inc 31.25%$ 31.250 millions
Takeda Pharmaceutical Company Limited30.34%$ 30.344 millions
Orasure Technologies Inc28.99%$ 28.987 millions
Conmed Corporation24.40%$ 24.402 millions
The Pennant Group Inc 22.84%$ 22.837 millions
Inmode Ltd 22.54%$ 22.535 millions
Option Care Health Inc 20.30%$ 20.299 millions
Vertex Pharmaceuticals Inc18.31%$ 18.305 millions
Avenue Therapeutics Inc 17.75%$ 17.748 millions
Steris Plc14.29%$ 14.287 millions
Medpace Holdings Inc 14.02%$ 14.021 millions
Zoetis Inc 13.70%$ 13.696 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com